BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:PUBLISH X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VTIMEZONE TZID:Eastern Standard Time BEGIN:STANDARD DTSTART:16011104T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 END:STANDARD BEGIN:DAYLIGHT DTSTART:16010311T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT CLASS:PUBLIC CREATED:20250513T142923Z DESCRIPTION:Innovation in Oral Cancer Risk Prediction - The STRATICYTETM Te st in Clinical Practice.\n \nClick the link to join the webinar at: https: //www.banty.org/peerperspective \n \nDr. Joel M. Laudenbach\n* DMD Diploma te\, \n* American Boards of Oral Medicine & Dental Sleep Medicine\, \n* Cl inical Associate Professor of Oral Medicine\,\n* Atrium Health Oral Medici ne & Maxillofacial Surgery\n \nDr. Paras Patel\n* DDS Board Certified Oral and Maxillofacial Pathologist\,\n* Director of the Oral Maxillofacial Pat hology Department at Propath\,\n* Owner and co-founder of the Center for O ral Pathology\, Dallas Texas\,\n* Principal US Lab Director\, Proteocyte\n \nKey Objectives:\nJoin Dr. Joel M. Laudenbach\, Dr. Paras Patel\, and co -panelist Dr. Jaisri Thoppay\, AAOM President-Elect\, for an interactive\n discussion that includes a review of the challenges faced with the current standard of care\, and how innovations like\nSTRATICYTE are looking to tr ansform oral precancer management. Our speakers will cover the science and data behind\nthe novel STRATICYTE test while sharing examples of how STRA TICYTE is used in practice to support decision making\nand compliance\, in cluding feedback from patients.\n DTEND;TZID="Eastern Standard Time":20250611T200000 DTSTAMP:20211001T162722Z DTSTART;TZID="Eastern Standard Time":20250611T190000 LAST-MODIFIED:20250513T142923Z LOCATION:online at https://www.banty.org/peerperspective PRIORITY:5 SEQUENCE:0 SUMMARY;LANGUAGE=en-ca:Innovation in Oral Cancer Risk Prediction - The STRA TICYTETM Test in Clinical Practice. TRANSP:OPAQUE UID:040000008200E00074C5B7101A82E00800000000C0D03571BFB6D701000000000000000 010000000166AB24464D71442824EFE5D36E3AFA2 X-ALT-DESC;FMTTYPE=text/html:\n\n\n

Innovation in O ral Cancer Risk Prediction - The STRATICYTE^TM Test in Clinical Practice.

\;

~~Click the link to join the webinar at: https://www.banty.org/peerperspective~~

\;

~~Dr. Joel M. Laudenbach~~

~~DMD Diplomate\,~~
~~American Boards of Oral Medicine &\; Dental Sleep Medicine\,~~
~~Clinical Associ ate Professor of Oral Medicine\,~~
~~Atrium Health Oral Medicine &\; Maxillofacial Surgery~~

~~&nbs p\;~~

~~Dr. Paras Patel~~

~~DDS Board Certified Oral and Maxillofacial Pathologist\,~~
~~Director of the Oral Maxillofacial Pathology Department at Propath\,~~
~~Owner and co-founder of the Center for Oral Pathology\, Dallas Texas \,~~
~~Principal US Lab Director\, Proteocyte~~

\;

~~Key Objectives:~~

~~Join Dr. Joel M. Laudenbach\, Dr. Paras Patel\, and c o-panelist Dr. Jaisri Thoppay\, AAOM President-Elect\, for an interactive< o:p>~~

~~discussion that includes a review of the cha llenges faced with the current standard of care\, and how innovations like~~

~~STRATICYTE are looking to transform oral pr ecancer management. Our speakers will cover the science and data behind~~

~~the novel STRATICYTE test while sharing exampl es of how STRATICYTE is used in practice to support decision making~~

~~and compliance\, including feedback from patients.~~

~~X-MICROSOFT-CDO-BUSYSTATUS:BUSY X-MICROSOFT-CDO-IMPORTANCE:1 X-MICROSOFT-DISALLOW-COUNTER:FALSE X-MS-OLK-AUTOFILLLOCATION:FALSE X-MS-OLK-CONFTYPE:0 END:VEVENT END:VCALENDAR~~